An approach to solvent screening for crystallization of polymorphic pharmaceuticals and fine chemicals
Authors:
- 1 July 2005
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 94 (7) , 1560-1576
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Crystal engineering – nucleation, the key stepCrystEngComm, 2002
- Theoretical hydrogen bonding parameters for drug designJournal of Molecular Graphics and Modelling, 2001
- Crystallisation of Polymorphs: Thermodynamic Insight into the Role of SolventOrganic Process Research & Development, 2000
- Hydrogen Bonding Parameters for QSAR: Comparison of Indicator Variables, Hydrogen Bond Counts, Molecular Orbital and Other ParametersJournal of Chemical Information and Computer Sciences, 1998
- Interactions at the organic/inorganic interface: binding motifs for phosphonates at the surface of barite crystalsJournal of the Chemical Society, Faraday Transactions, 1991
- Hydrogen bonding. Part 9. Solute proton donor and proton acceptor scales for use in drug designJournal of the Chemical Society, Perkin Transactions 2, 1989
- Electronegativity and bond energyJournal of the American Chemical Society, 1983
- Linear solvation energy relationships. 16. Dipole/dipole contributions to formation constants of some "hydrogen bonded complexes"The Journal of Organic Chemistry, 1982
- A New Electroaffinity Scale; Together with Data on Valence States and on Valence Ionization Potentials and Electron AffinitiesThe Journal of Chemical Physics, 1934
- THE NATURE OF THE CHEMICAL BOND. IV. THE ENERGY OF SINGLE BONDS AND THE RELATIVE ELECTRONEGATIVITY OF ATOMSJournal of the American Chemical Society, 1932